Climb Bio

Climb Bio

Committed to developing better treatments for patients with immune-mediated diseases

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Climb Bio. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
46 people
Headquarters
Wellesley, MA
Founded
2018
Type
Public Company
Total funding
$401.3M

Immune-mediated diseases impact 1:7 people and are increasing in prevalence worldwide. They occur when the immune system mistakenly attacks the tissues of the body and can result in permanent organ damage or even death. Despite advances in treatment, many patients with immune-mediated diseases suffer from poor outcomes when their disease cannot be controlled with available therapies. At Climb Bio, we believe that we can impact the pathways that cause immune-mediated diseases to give patients precious time free of disease.

biotech clinical development and Immunology

Open roles at Climb Bio